MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $175 | +49.6% | 1,203 | +139.2% | 0.00% | – |
Q2 2023 | $117 | -14.6% | 503 | -11.1% | 0.00% | – |
Q1 2023 | $137 | -13.3% | 566 | +4.2% | 0.00% | – |
Q4 2022 | $158 | -99.5% | 543 | 0.0% | 0.00% | – |
Q3 2022 | $35,000 | -10.3% | 543 | 0.0% | 0.00% | – |
Q2 2022 | $39,000 | -31.6% | 543 | 0.0% | 0.00% | – |
Q1 2022 | $57,000 | +23.9% | 543 | 0.0% | 0.00% | – |
Q4 2021 | $46,000 | +4.5% | 543 | 0.0% | 0.00% | – |
Q3 2021 | $44,000 | -17.0% | 543 | 0.0% | 0.00% | – |
Q2 2021 | $53,000 | -43.0% | 543 | -32.9% | 0.00% | – |
Q1 2021 | $93,000 | +3.3% | 809 | 0.0% | 0.00% | – |
Q4 2020 | $90,000 | -6.2% | 809 | 0.0% | 0.00% | – |
Q3 2020 | $96,000 | +5.5% | 809 | 0.0% | 0.00% | – |
Q2 2020 | $91,000 | +160.0% | 809 | +54.7% | 0.00% | – |
Q1 2020 | $35,000 | -25.5% | 523 | 0.0% | 0.00% | – |
Q4 2019 | $47,000 | -54.4% | 523 | -46.9% | 0.00% | – |
Q2 2019 | $103,000 | -16.3% | 985 | 0.0% | 0.00% | – |
Q1 2019 | $123,000 | +15.0% | 985 | 0.0% | 0.00% | – |
Q4 2018 | $107,000 | -19.5% | 985 | +59.1% | 0.00% | – |
Q3 2018 | $133,000 | -23.1% | 619 | 0.0% | 0.00% | – |
Q2 2018 | $173,000 | +140.3% | 619 | 0.0% | 0.00% | – |
Q1 2018 | $72,000 | +26.3% | 619 | 0.0% | 0.00% | – |
Q4 2017 | $57,000 | – | 619 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |